Search

Search Constraints

You searched for: Author/Creator Lock, Richard

Search Results

3. Initial testing (stage 1) of eribulin, a novel tubulin binding agent, by the pediatric preclinical testing program. Issue 8 (28th March 2013)

4. Initial Testing (Stage 1) of MK‐8242—A Novel MDM2 Inhibitor—by the Pediatric Preclinical Testing Program. Issue 10 (30th May 2016)

5. Initial testing (stage 1) of temozolomide by the pediatric preclinical testing program1. Issue 5 (17th January 2013)

6. Initial testing (stage 1) of the curaxin CBL0137 by the pediatric preclinical testing program. Issue 4 (21st September 2016)

7. Initial testing (stage 1) of the histone deacetylase inhibitor, quisinostat (JNJ‐26481585), by the Pediatric Preclinical Testing Program. Issue 2 (4th September 2013)

8. Initial testing (stage 1) of the investigational mTOR kinase inhibitor MLN0128 by the pediatric preclinical testing program. Issue 8 (20th February 2014)

9. Initial testing (stage 1) of the PARP inhibitor BMN 673 by the pediatric preclinical testing program: PALB2 mutation predicts exceptional in vivo response to BMN 673. Issue 1 (27th September 2014)

10. Initial testing (stage 1) of the phosphatidylinositol 3′ kinase inhibitor, SAR245408 (XL147) by the pediatric preclinical testing program1. Issue 5 (21st September 2012)